162 related articles for article (PubMed ID: 30910461)
1. Thiazolyl-pyrazole derivatives as potential antimycobacterial agents.
Takate SJ; Shinde AD; Karale BK; Akolkar H; Nawale L; Sarkar D; Mhaske PC
Bioorg Med Chem Lett; 2019 May; 29(10):1199-1202. PubMed ID: 30910461
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
Abhale YK; Shinde A; Shelke M; Nawale L; Sarkar D; Mhaske PC
Bioorg Chem; 2021 Oct; 115():105192. PubMed ID: 34314920
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives.
Abhale YK; Sasane AV; Chavan AP; Shekh SH; Deshmukh KK; Bhansali S; Nawale L; Sarkar D; Mhaske PC
Eur J Med Chem; 2017 May; 132():333-340. PubMed ID: 28411559
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
[TBL] [Abstract][Full Text] [Related]
7. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial evaluation of novel [4,5-dihydro-1H-pyrazole-1-carbonyl]pyridine derivatives synthesized by microwave-mediated Michael addition.
Sedighi V; Azerang P; Sardari S
Drug Test Anal; 2015 Jun; 7(6):550-4. PubMed ID: 25219796
[TBL] [Abstract][Full Text] [Related]
9. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
Manikannan R; Venkatesan R; Muthusubramanian S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2010 Dec; 20(23):6920-4. PubMed ID: 20970331
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK
Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
Narender M; Jaswanth S B; Umasankar K; Malathi J; Raghuram Reddy A; Umadevi KR; Dusthackeer AVN; Venkat Rao K; Raghuram R A
Bioorg Med Chem Lett; 2016 Feb; 26(3):836-840. PubMed ID: 26755393
[TBL] [Abstract][Full Text] [Related]
13. 2-Aminoaryl-3,5-diaryl pyrazines: Synthesis, biological evaluation against Mycobacterium tuberculosis and docking studies.
Gangarapu NR; Ranganatham A; Reddy EK; Yellappa S; Chandrasekhar KB
Arch Pharm (Weinheim); 2020 Jul; 353(7):e1900368. PubMed ID: 32399980
[TBL] [Abstract][Full Text] [Related]
14. New thiazolyl-pyrazoline derivatives bearing nitrogen mustard as potential antimicrobial and antiprotozoal agents.
Cuartas V; Robledo SM; Vélez ID; Crespo MDP; Sortino M; Zacchino S; Nogueras M; Cobo J; Upegui Y; Pineda T; Yepes L; Insuasty B
Arch Pharm (Weinheim); 2020 May; 353(5):e1900351. PubMed ID: 32187709
[TBL] [Abstract][Full Text] [Related]
15. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases.
Jose G; Suresha Kumara TH; Sowmya HBV; Sriram D; Guru Row TN; Hosamani AA; More SS; Janardhan B; Harish BG; Telkar S; Ravikumar YS
Eur J Med Chem; 2017 May; 131():275-288. PubMed ID: 28340368
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
Emmadi NR; Bingi C; Kotapalli SS; Ummanni R; Nanubolu JB; Atmakur K
Bioorg Med Chem Lett; 2015 Aug; 25(15):2918-22. PubMed ID: 26048808
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial and cytotoxic activities of new N-3 substituted thiazolidine-2,4-dione derivatives bearing the pyrazole moiety.
Desai NC; Satodiya HM; Kotadiya GM; Vaghani HV
Arch Pharm (Weinheim); 2014 Jul; 347(7):523-32. PubMed ID: 24729458
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents.
Cihan-Üstündağ G; Capan G
Mol Divers; 2012 Aug; 16(3):525-39. PubMed ID: 22893206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
